Treatment Strategy for Rifampin-Susceptible Tuberculosis
N Engl J Med
.
2023 Jun 15;388(24):2297-2298.
doi: 10.1056/NEJMc2304776.
Authors
Chi Chiu Leung
1
,
Giovanni B Migliori
2
Affiliations
1
Hong Kong Tuberculosis, Chest, and Heart Diseases Association, Hong Kong, China
[email protected]
.
2
Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
PMID:
37314716
DOI:
10.1056/NEJMc2304776
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Rifampin* / therapeutic use
Tuberculosis* / drug therapy
Substances
Rifampin